Table 1. Baseline clinical characteristics of 29 cases with synchronous bilateral multiple nodules.
| No. | Sex | Age (years) | Smoking | Imaging manifestation |
TM | Comorbidity | Pulmonary function |
|||
|---|---|---|---|---|---|---|---|---|---|---|
| CF | No. (R/L) | Location (R/L) | FEV1 (mL) | FEV1% pred | ||||||
| 1 | M | 62 | N | p/pGGO | 1/1 | U-U | H | 2,700 | 106.5 | |
| 2 | F | 61 | N | m/m/pGGO | 2/1 | U/L-U | N | DM | 2,650 | 101.2 |
| 3a | F | 52 | N | SN/SN | 1/1 | U-U | N | 2,610 | 101.3 | |
| 4 | M | 63 | Y | p/pGGO | 1/1 | U-U | N | 2,810 | 104.4 | |
| 5 | F | 51 | N | m/pGGO | 1/1 | U-U | N | 3,170 | 111.5 | |
| 6 | F | 60 | N | p/p/mGGO | 2/1 | U/L-L | H | DM | 2,300 | 112.4 |
| 7 | M | 18 | N | SN/SN | 1/1 | U-U | N | 3,060 | 111.1 | |
| 8b | M | 53 | N | p/pGGO | 1/1 | U-U | H | HBP | 2,870 | 109.8 |
| 9c | F | 55 | N | SN/SN | 1/1 | U-U | N | DM | 2,900 | 99.7 |
| 10 | M | 66 | Y | m/mGGO | 1/1 | U-U | N | DM, HBP | 3,240 | 94.0 |
| 11 | F | 51 | N | m/pGGO | 1/1 | L-L | N | 2,170 | 112.0 | |
| 12 | M | 70 | Y | m/mGGO/SN | 2/1 | M/L-U | N | 2,470 | 102.8 | |
| 13 | M | 62 | Y | SN/m/pGGO | 2/1 | U/M-U | N | DM, HBP | 3,210 | 100.5 |
| 14 | F | 54 | N | p/pGGO | 1/1 | U-L | H | 2,210 | 100.1 | |
| 15 | M | 59 | N | SN/SN | 1/1 | U-U | H | 2,490 | 99.2 | |
| 16 | F | 55 | N | mGGO/SN | 1/1 | L-U | N | 2,080 | 104.5 | |
| 17 | M | 42 | Y | SN/SN | 1/1 | M-L | H | 4,550 | 107.6 | |
| 18 | F | 62 | Y | p/mGGO | 1/1 | U-L | N | 2,580 | 92.8 | |
| 19 | F | 59 | N | m/mGGO | 1/1 | U-U | N | 2,480 | 103.8 | |
| 20 | F | 57 | N | m/pGGO | 1/1 | U-U | N | 2,690 | 113.3 | |
| 21 | M | 65 | N | m/pGGO | 1/1 | U-U | H | 2,100 | 84.8 | |
| 22 | F | 67 | N | m/p/pGGO | 2/1 | U/L-U | N | 2,580 | 97.4 | |
| 23 | F | 66 | N | m/p/pGGO | 2/1 | U/M-U | N | 1,860 | 105.7 | |
| 24d | M | 53 | Y | SN/SN | 1/1 | U-U | N | 2,100 | 96.8 | |
| 25 | F | 43 | N | SN/pGGO | 1/1 | L-L | N | 2,800 | 93.3 | |
| 26 | M | 68 | Y | SN/SN | 1/1 | L-U | N | DM | 1,920 | 101.4 |
| 27 | M | 71 | N | m/mGGO | 1/1 | L-L | N | 1,530 | 115.0 | |
| 28 | M | 56 | N | p/pGGO | 1/1 | U-L | N | 2,480 | 101.2 | |
| 29 | F | 49 | N | p/pGGO | 1/1 | U-U | N | 2,690 | 104.3 | |
a, breast cancer; b, thyroid carcinoma; c, parotid carcinoma; d, rectal cancer; F, female; M, male; Y, yes; N, no; CF, classification; pGGO, pure ground glass opacity; mGGO, mixed ground glass opacity; SN, solid nodule; G/S, pGGO plus SN; R, right; L, left; U/M/L, upper/middle/lower lobe; TM, serum tumor marker; H, high; N, normal; FEV1, forced expiratory volume in 1 second; FEV1% pred, FEV1%/(mean FEV1%); DM, diabetes mellitus; HBP, high blood pressure.